CPT Code 83036 Billing Tips

BCBSWY would like to encourage Providers billing CPT code 83036 to include the category claims as this will be a focus beginning Jan. 1, 2024.

For best habits, please begin using the below guidance now to ensure proper categorization.

CPT 83036 for a HbA1c laboratory test will need the appropriate Category II code on the same claim.

CAT II codes are an informational code and should be billed with either a $0.00 charge or a $0.01 charge if required by your system or clearing house.

CAT II codes are for diagnostic/ screening processes or results.

Category II Codes for HgbA1c

Codes Code Usage

  • 3044F-HbA1c —– Less than 7.0%
  • 3051F-HbA1c —– Greater than or equal to 7.0% and less than 8.0%
  • 3052F-HbA1c —– Greater than or equal to 8.0% and less than 9.0%
  • 3046F-HbA1c —– Greater than 9.0%

Annual Wellness Reminders

BCBSWY encourages Primary Care Providers to remind your patients to schedule an annual wellness visit. Annual exams are essential. We know that regular preventive care is one of the best ways to identify and treat health issues before they get worse.

Click here to see the complete list of preventive benefits that BCBSWY covers.

Provider Directory Validation Tool Reminder

Reminder:

  • You can now find the guide under the ProviderResources section on the right of the website.
  • Providers can use the Directory Validation tool on the Availity Portal to find NPI and tax ID combinations.
  • The No Surprises Act (NSA) requires you confirm this information with us every 90 days.
Provider Resources:

Share

Related Posts
BCBSWY Provider Manual Update: New Dispute Resolution Process Now in Effect
As of July 30, 2025, Blue Cross Blue Shield of Wyoming has officially updated the Dispute Resolution Process outlined in the Provider Manual and…
BCBSWY Health Care Providers: New Credentialing Law Now in Effect
As of July 1, 2025, Wyoming House Bill 82 has officially taken effect, introducing important updates to the credentialing and recredentialing process for health…
BCBSWY Humira Update
Effective July 1, 2025, Hadlima, Simlandi, adalimumab-aaty, adalimumab-adaz will be the preferred biosimilar products on all BCBSWY formularies while Humira is being removed from…

Fewer Hassles. Better Service.

ACA – Online Event Registration Form

Please enable JavaScript in your browser to complete this form.
Name
Email
How did you hear about this event?

Medicare - Event Registration
Medicare - Online Event Registration Form
Please enable JavaScript in your browser to complete this form.
Name
Email
How did you hear about this event?